相关实验视频

Updated: Jun 13, 2025

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

索福斯布维尔作为黄热病相关的内性疾病 (YEL-AVD) 的暴露后预防

Jessica Barrett¹, Ernest Muntengesa², Clare Warrell³

¹Department of Infection, North Bristol NHS Trust, Bristol, UK.

The Journal of antimicrobial chemotherapy

|January 17, 2025

概括

在高风险患者中,索福斯布维尔可以预防黄热病相关的内性疾病 (YEL-AVD). 一个案例研究表明,在黄热病疫苗接种后使用索福斯布维尔进行暴露后预防后,没有YEL-AVD的发展.

科学领域:

病毒学病毒学
疫苗学疫苗学疫苗学
药理学药理学是指药理学的学科.

背景情况:

黄热病相关的内性疾病 (YEL-AVD) 是黄热病疫苗接种后的一种罕见但严重的并发症.
患有甲状腺切除术史的个人有增加YEL-AVD.风险.
目前,对于高死亡率的YEL-AVD,没有确立的基于证据的治疗方法.

研究的目的:

评估非标签索福斯布维尔作为YEL-AVD暴露后预防的疗效.
评估患者的临床和病毒学反应,尽管有风险因素,但无意中接种了黄热病疫苗.

主要方法:

一位患有甲状腺切除病史的患者接受了黄热病疫苗.
该患者接受了14天的口服索福斯布维尔治疗,作为暴露后预防.
定期进行临床和生化监测.

主要成果:

患者没有出现YEL-AVD的临床症状.
没有观察到与索福斯布维尔治疗相关的副作用.
患者在整个治疗期间保持良好状态.

结论:

索福斯布维尔作为暴露后预防剂,有望在高风险人群中预防YEL-AVD.
需要进行进一步的临床试验,以确定索福斯布维尔对黄热病感染和YEL-AVD预防的疗效.

更多相关视频

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

Published on: October 30, 2021

相关概念视频

Retroviruses

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...